92 related articles for article (PubMed ID: 3802112)
1. Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.
Craig JB; Powell BL; Jackson DV; Atkins JN; Smith LR; White DR; Richards F; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):151-3. PubMed ID: 3802112
[No Abstract] [Full Text] [Related]
2. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
[No Abstract] [Full Text] [Related]
3. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Sandler S; Bonomi P; Taylor B; Showel J; Slayton R; Lerner H
Cancer Treat Rep; 1984 Sep; 68(9):1163-5. PubMed ID: 6541095
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
[TBL] [Abstract][Full Text] [Related]
8. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
9. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
Argiris A; Li Y; Murphy BA; Langer CJ; Forastiere AA
J Clin Oncol; 2004 Jan; 22(2):262-8. PubMed ID: 14722034
[TBL] [Abstract][Full Text] [Related]
10. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.
Powell BL; Craig JB; Muss HB; Zekan PJ; Cooper MR; Schnell FM; Hampton JW; White DR; Smith LR; Capizzi RL
Am J Clin Oncol; 1988 Oct; 11(5):550-2. PubMed ID: 3177257
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Benner SE; Lippman SM; Huber MH; Hong WK
Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
[TBL] [Abstract][Full Text] [Related]
16. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
Baghi M; Hambek M; Wagenblast J; May A; Gstoettner W; Knecht R
Anticancer Res; 2006; 26(1B):585-90. PubMed ID: 16739325
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative group.
Benasso M; Ponzanelli A; Merlano M; Numico G; Ricci I; Vigo V; Grossi F; Amadori D; Cavallo G; Capaccetti B; Taveggia P; Boni L; Rosso R
Acta Oncol; 2006; 45(2):168-74. PubMed ID: 16546862
[TBL] [Abstract][Full Text] [Related]
19. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
[No Abstract] [Full Text] [Related]
20. Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.
Merlano M; Tatarek R; Grimaldi A; Margarino G; Rosso R
Cancer Treat Rep; 1985 Sep; 69(9):961-4. PubMed ID: 4040809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]